Lineage Cell Therapeutics (LCTX)
(Delayed Data from AMEX)
$1.17 USD
-0.12 (-9.30%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $1.16 -0.01 (-0.85%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | -0.03 |
Last EPS Surprise | 57.14% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.18 |
Next Year | -0.15 |
EPS (TTM) | -0.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.59M | 3.65M | 19.88M | 12.73M |
# of Estimates | 1 | 1 | 3 | 3 |
High Estimate | 3.59M | 3.65M | 35.30M | 25.30M |
Low Estimate | 3.59M | 3.65M | 9.44M | 3.34M |
Year ago Sales | 2.39M | 3.23M | 8.94M | 19.88M |
Year over Year Growth Est. | 50.21% | 13.00% | 122.25% | -35.99% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | -0.04 | -0.18 | -0.15 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.04 | -0.04 | -0.11 | -0.07 |
High Estimate | -0.02 | -0.03 | -0.11 | -0.07 |
Low Estimate | -0.05 | -0.05 | -0.24 | -0.22 |
Year ago EPS | -0.03 | -0.03 | -0.12 | -0.18 |
Year over Year Growth Est. | -33.33% | -33.33% | -50.00% | 18.06% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 1 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.04 | -0.04 | -0.18 | -0.15 |
7 Days Ago | -0.04 | -0.04 | -0.18 | -0.15 |
30 Days Ago | NA | NA | -0.16 | -0.12 |
60 Days Ago | NA | NA | -0.16 | -0.12 |
90 Days Ago | NA | NA | -0.16 | -0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.04 | -0.04 | -0.17 | -0.15 |
Zacks Consensus Estimate | -0.04 | -0.04 | -0.18 | -0.15 |
Earnings ESP | 0.00% | 0.00% | 6.85% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.03 | -0.04 | -0.03 | -0.03 | NA |
Estimate | -0.07 | -0.04 | -0.04 | -0.03 | NA |
Difference | 0.04 | 0.00 | 0.01 | 0.00 | 0.01 |
Surprise | 57.14% | 0.00% | 25.00% | 0.00% | 20.54% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more